McRae Marc P
Department of Basic Sciences, National University of Health Sciences.
J Chiropr Med. 2020 Mar;19(1):58-64. doi: 10.1016/j.jcm.2019.10.008. Epub 2020 Aug 29.
The purpose of this narrative review is to determine whether published meta-analyses support the use of fiber supplementation in the treatment of constipation, weight loss, and dietary support for gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease.
A PubMed search from January 1, 1980, to July 31, 2019, was conducted with the following search strategy: (fiber OR fibre) AND (meta-analysis OR systematic review) AND (constipation OR body weight OR obesity OR irritable bowel syndrome OR inflammatory bowel disease). Meta-analyses that provided quantitative statistical analysis with a measured effect size were retrieved and accepted into this review. The following was extracted and entered into an Excel spreadsheet: number of publications included in the meta-analysis, number of total participants, fiber type and daily dose, pooled treatment effects for clinical endpoints, or summary relative risks.
Eighteen meta-analyses support dietary fiber supplementation for patients with constipation, weight loss, and IBS, but the significant heterogeneity and publication bias undermine the support for using dietary fiber supplementation in these conditions.
This narrative review of meta-analyses finds some benefits for recommending fiber supplementation to patients with constipation, obesity, and IBS, but significant heterogeneity and publication bias undermine this support.
本叙述性综述的目的是确定已发表的荟萃分析是否支持补充膳食纤维用于治疗便秘、减肥以及为肠易激综合征(IBS)和炎症性肠病等胃肠道疾病提供饮食支持。
采用以下检索策略对1980年1月1日至2019年7月31日期间的PubMed进行检索:(纤维或纤维素)与(荟萃分析或系统评价)与(便秘或体重或肥胖或肠易激综合征或炎症性肠病)。检索并纳入本综述的是那些提供了具有测量效应大小的定量统计分析的荟萃分析。提取以下内容并录入Excel电子表格:荟萃分析中纳入的出版物数量、总参与者数量、纤维类型和每日剂量、临床终点的合并治疗效果或汇总相对风险。
18项荟萃分析支持对便秘、减肥和肠易激综合征患者补充膳食纤维,但显著的异质性和发表偏倚削弱了在这些情况下使用膳食纤维补充剂的依据。
本对荟萃分析的叙述性综述发现,向便秘、肥胖和肠易激综合征患者推荐补充膳食纤维有一些益处,但显著的异质性和发表偏倚削弱了这种支持。